Initial Public Offerings

Amid ₹1.85-trn fund raise, here are 5 lessons from IPO investing in 2025

The year 2025 has seen over 100 mainboard, and 250+ SME IPOs. From frenzied demand to aggressive pricing among others, here are the key learnings from IPO investing as per experts.

Finance Ministry asks three RRBs to give IPO blueprint by March-end

The DFS on Tuesday convened a meeting to review the IPO plans of three regional rural banks-Haryana Gramin Bank, Kerala Gramin Bank and Tamil Nadu Grama Bank

Bombay High Court ruling throws light on misuse of petitions to stall IPOs

Experts call for frameworks to identify, deter vexatious legal challenges

Sebi approves IPOs for Yashoda Healthcare, Orient Cables, 5 others

As many as seven companies, including Yashoda Healthcare Services, Fusion CX and Orient Cables, have secured Sebi's approval to raise funds through initial public offerings (IPOs), data with the markets regulator showed on Tuesday. Other firms that received regulatory approvals are Turtlemint Fintech Solutions, RSB Retail India, SFC Environmental Technologies, and Lohia Corp. Together, these companies are expected to fetch over Rs 6,000 crore, market sources said. These seven companies approached Sebi between May and September, obtained its observations during December 8-12, the update showed. In Sebi's parlance, receiving observations is equivalent to its go-ahead to proceed with a public issue. In Yashoda Healthcare Services, the company filed draft papers with Sebi in September through a confidential route for raising funds through its maiden public offering. According to market sources, the IPO size is expected to be anywhere between Rs 3,000 and Rs 4,000 crore. Turtlemint F

Peer-to-peer lending platform LenDenClub's parent plans IPO, says CEO

Peer-to-peer lending connects individual lenders directly with borrowers, bypassing banks and other financial institutions

IPOs worth $20 billion per annum are the 'new normal' for India: JP Morgan

Initial public offerings worth USD 20 billion per annum are the "new normal" for India and will become an annualised run rate over the next few years, one of the biggest investment bankers said on Tuesday. The market, which has seen a slew of initial share sales this fiscal, has already witnessed USD 21 billion of issuances in 2025, the same as last year, and we should close the year with over USD 23 billion, given the fact that some large issues like the Rs 10,000 offering from ICICI Prudential AMC are in process, said JP Morgan. "Yearly issuance of USD 20 billion is the new normal for India. It is the new watermark and will become an annualized run rate from here on," its head of equity capital markets, Abhinav Bharti, told reporters here. Bharti said nearly a fifth of the demand is getting driven by consumer technology and new age businesses, and the same will go above 30 per cent as well over the next five years. He said at least 20 startups, which command valuations in hundred

Street Signs: Fundraising opens up; anchor row twist; F&O stretches

A packed fundraising calendar, an anchor-allocation flashpoint, and a major shift in derivatives trading set the stage for one of the busiest - and most closely watched - weeks in markets

Meesho, Aequs, and Vidya Wires IPOs overall bid exceeds ₹3 trillion

Meesho, Aequs and Vidya Wires drew bids worth nearly Rs 3 trillion, with institutional investors driving subscriptions as high as 120 times the shares on offer

Mainboard IPOs score a century for the first time after 18 years

Mainboard IPO launches have hit 100 for the first time since 2007, with mobilisation set to cross Rs 1.7 trillion, powered by strong domestic inflows, steady PE exits and resilient demand

NephroPlus plans global scale-up ahead of IPO amid rising CKD burden

India's largest dialysis provider plans to expand clinics at home and abroad ahead of its December 10 IPO, betting on rising CKD burden and demand for accessible dialysis care

Corona Remedies bets on female hormone complex generics ahead of IPO

Corona Remedies is pushing into female hormone complex generics to expand beyond India, as its Rs 655.3-crore OFS IPO opens December 8, with a new hormone plant and a stake in La Chandra Pharma Labs

Street Signs: Flexicaps lead MF space; IPO street set to buzz again

Flexible equity schemes top assets and inflows as investors turn cautious in a patchy market

Wakefit to float IPO on Dec 8, aims to raise ₹377 cr via fresh issue

Home and furnishings company Wakefit Innovations is set to launch its initial public offering (IPO) on December 8, comprising a fresh issue of shares worth Rs 377 crore. The IPO of the Bengaluru-based company will conclude on December 10, and anchor investors will be allocated shares on December 5, according to the red herring prospectus (RHP). The company's maiden public offering is a combination of a fresh issue of equity shares aggregating up to Rs 377.1 crore and an offer-for-sale (OFS) of 4.67 crore shares by the selling shareholders. As part of the OFS, the promoters - Ankit Garg and Chaitanya Ramalingegowda and other selling shareholders - Nitika Goel, Peak XV Partners Investments VI, Redwood Trust, Verlinvest S.A., SAI Global India Fund I LLP, Investcorp Growth Equity Fund, Investcorp Growth Opportunity Fund and Paramark KB Fund I will be offloading shares. Wakefit proposes to utilize the proceeds from the fresh issue, worth Rs 31 crore, for setting up 117 new COCO Regular

IPO pipeline swells as 2 dozen firms plan ₹40,000 cr offerings in Dec-Jan

The IPO momentum shows no signs of slowing, with another two dozen companies, including ICICI Prudential AMC, Meesho and Juniper Green Energy, preparing to launch their public issues that could collectively raise nearly Rs 40,000 crore over the next two months, merchant bankers said. Adding to this robust pipeline are prominent names such as artificial intelligence firm Fractal Analytics, home and sleep solutions brand Wakefit Innovations, technology-led security and surveillance firm Innovatiview India, and hospital chain Park Medi World, they added. This exceptional pipeline not only reflected the confidence of issuers but also highlighted investors' appetite to seize listing-day gains or back companies with strong long-term growth potential. Moreover, companies across the spectrum -- large, mid- and small-caps -- are gearing up to tap the IPO route in the coming weeks. Experts attribute this momentum to rising retail participation and resilient domestic inflows, which have been

The primary rush: Annual IPO haul set to hit ₹1.6 trn milestone next week

India's IPO market is on track to surpass last year's record haul, with fundraising likely to cross Rs 1.6 trillion and the number of issuances hitting their highest level since 2007

Sudeep Pharma IPO sees solid anchor demand, positive GMP; worth your money?

Sudeep Pharma IPO opens for subscription: Check price band, lot size, GMP, reviews, allotment date, listing date, and other key details here

Pajson Agro receives in-principle approval from BSE to raise funds via IPO

City-based Pajson Agro India on Thursday said it has received in-principle approval from BSE Ltd to raise funds through an initial public offering in the SME category. The initial public offer (IPO) is entirely a fresh issue of a little over 63.09 lakh shares with a face value of Rs 10 each, according to the draft red herring prospectus (DRHP). The net proceeds of Rs 57 crore from the fresh issue will be used to set up a second cashew processing facility in Vizianagaram, Andhra Pradesh, and for general corporate purposes. Incorporated in 2021, Pajson Agro India is engaged in processing raw cashew nuts into kernels for domestic and international markets. The company offers various grades of cashew nuts, processed and packaged in both bulk and consumer retail packs, and markets select dry fruits under its brand "Royal Mewa" through a mix of e-commerce platforms and offline distribution channels. It also supplies its products to various entities like Bikanervala, More Retail, Nutraj,

Street Signs: Nifty claws towards 26,500, IPO ticker tape parade, and more

With total fundraising in 2025 already exceeding ₹1.5 trillion, the market is within striking distance of last year's record of ₹1.59 trillion

PhysicsWallah IPO subscribed 1.8 times on final day of the issue

PhysicsWallah's Rs 3,480 crore IPO closed with 1.8x subscription, boosted by strong institutional and employee interest as the edtech platform expands its online, offline, and hybrid learning network

SIFs garnered ₹2,005 crore net inflow in Oct; AUM stood at ₹2,010 crore

Mutual funds see new SIF inflows; BSE profit surges 61%; Sensex, Nifty end higher; gold hits 3-week high; PhysicsWallah, Pine Labs, and Emmvee IPOs draw investor attention